Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein

Monoclonal antibodies (mAbs) play an increasing important role in the therapeutic armamentarium against multiple sclerosis (MS), an inflammatory and degenerative disorder of the central nervous system. Most of the mAbs currently developed for MS are immunomodulators blocking the inflammatory immune...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:MAbs
Hlavní autoři: Curtin, François, Perron, Hervé, Kromminga, Arno, Porchet, Hervé, Lang, Alois B
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2014
Témata:
Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623301/
https://ncbi.nlm.nih.gov/pubmed/25427053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.985021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky